Age

4

Review clinical trials related to Age. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Effect of Audio-hypnosis on the Academic Performance of Nursing Students.

Exam stress significantly affects the mental health and cognitive functions of nursing students. Audio-hypnosis offers a practical and low-cost intervention. Objective: To evaluate the effect of a single audio-hypnosis session on perceived stress, heart rate, and academic results. Methods: A pilot randomized trial will be conducted with 20 second-year students at ISPITS Safi, divided into an intervention group and a control group (n=10 each). Anxiety (VAS), heart rate (HR), and exam grades were analyzed.

Participants needed: 20
Trial details
Biological sex: AllType: InterventionalSponsor: HASSAN 1st universityUpdated: Oct 7, 2026Locations: 1
Eligibility criteria

Students enrolled in the first year of nursing training at the Higher Institute... [+1]

Students who refuse to participate or do not sign consent. [+3]

Status: Not yet recruiting

Quality of Life of Patients Who Have Undergone Bilateral Mastectomy

The investigators therefore aim to determine whether the type of mastectomy (preventive in a high-risk patient or therapeutic in a patient with a history of cancer), as well as the timing (immediate or delayed) and type of breast reconstruction, influence the quality of life and satisfaction of patients who have undergone bilateral mastectomy. The goal of this observational study is thus to measure and compare the quality of life of patients who have undergone bilateral mastectomy using the BREAST-Q questionnaire.

Participants needed: 115
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: University Hospital, GrenobleUpdated: Jul 15, 2026
Eligibility criteria

Female sex [+4]

Individual under guardianship or curatorship, or deprived of liberty [+1]

Status: Recruiting

The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer

This study is a single-center, prospective/retrospective, observational clinical research designed to compare the differences in peripheral blood components between young and elderly HR+HER2- breast cancer patients, and to identify peripheral blood components that may affect the prognosis of young HR+HER2- breast cancer patients. The study population consists of early-stage HR+HER2- breast cancer patients receiving neoadjuvant therapy. Eligible patients who require neoadjuvant treatment will be enrolled in the study. Retrospective data and samples will be collected based on existing patient medical records and tissue biobank samples. Prospective data collection will be based on routine clinical treatment during the study period and will continue until the patient completes neoadjuvant therapy and undergoes primary tumor surgery, or until the study is prematurely terminated. HR+HER2- breast cancer patients receiving neoadjuvant therapy will be divided into young and elderly groups. Peripheral blood samples will be collected at baseline (T0, prior to treatment) and after two cycles of neoadjuvant therapy (T1). Paired baseline tumor biopsy samples and/or surgical tumor samples will also be collected. Peripheral blood and tumor samples will undergo appropriate tests. The study respects the investigator's choice of treatment, without specifying which drugs should be used, the dosage, the administration mode (including monotherapy, combination therapy, or sequential therapy), or the duration of treatment.

Participants needed: 120
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Fudan UniversityUpdated: Jan 21, 2026Locations: 1
Eligibility criteria

Signed informed consent according to local regulations; [+4]

Presence of distant metastasis; [+6]

Status: Recruiting

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.

Participants needed: 250
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Hennepin Healthcare Research InstituteUpdated: Jun 12, 2025Locations: 1
Eligibility criteria

Age>=18 years [+2]

Other significant immunosuppressing condition [+10]